Knudsen Gitte M, Fromberg Arvid, Ng Yin, Gram Lone
Department of Bioengineering, Technical University of Denmark Kongens Lyngby, Denmark.
National Food Institute, Technical University of Denmark Søborg, Denmark.
Front Microbiol. 2016 Jul 12;7:1091. doi: 10.3389/fmicb.2016.01091. eCollection 2016.
The human pathogenic bacterium Listeria monocytogenes is exposed to antibiotics both during clinical treatment and in its saprophytic lifestyle. As one of the keys to successful treatment is continued antibiotic sensitivity, the purpose of this study was to determine if exposure to sublethal antibiotic concentrations would affect the bacterial physiology and induce antibiotic tolerance. Transcriptomic analyses demonstrated that each of the four antibiotics tested caused an antibiotic-specific gene expression pattern related to mode-of-action of the particular antibiotic. All four antibiotics caused the same changes in expression of several metabolic genes indicating a shift from aerobic to anaerobic metabolism and higher ethanol production. A mutant in the bifunctional acetaldehyde-CoA/alcohol dehydrogenase encoded by lmo1634 did not have altered antibiotic tolerance. However, a mutant in lmo1179 (eutE) encoding an aldehyde oxidoreductase where rerouting caused increased ethanol production was tolerant to three of four antibiotics tested. This shift in metabolism could be a survival strategy in response to antibiotics to avoid generation of ROS production from respiration by oxidation of NADH through ethanol production. The monocin locus encoding a cryptic prophage was induced by co-trimoxazole and repressed by ampicillin and gentamicin, and this correlated with an observed antibiotic-dependent biofilm formation. A monocin mutant (ΔlmaDCBA) had increased biofilm formation when exposed to increasing concentration of co-trimoxazole similar to the wild type, but was more tolerant to killing by co-trimoxazole and ampicillin. Thus, sublethal concentrations of antibiotics caused metabolic and physiological changes indicating that the organism is preparing to withstand lethal antibiotic concentrations.
人类病原菌单核细胞增生李斯特菌在临床治疗期间及其腐生生活方式中都会接触到抗生素。由于成功治疗的关键之一是持续保持抗生素敏感性,本研究的目的是确定暴露于亚致死浓度的抗生素是否会影响细菌生理学并诱导抗生素耐受性。转录组分析表明,所测试的四种抗生素中的每一种都会导致与特定抗生素作用方式相关的抗生素特异性基因表达模式。所有四种抗生素都导致几个代谢基因的表达发生相同变化,表明从有氧代谢转变为无氧代谢以及乙醇产量增加。由lmo1634编码的双功能乙醛 - 辅酶A/醇脱氢酶突变体的抗生素耐受性没有改变。然而,编码醛氧化还原酶的lmo1179(eutE)突变体,其代谢途径改变导致乙醇产量增加,对所测试的四种抗生素中的三种具有耐受性。这种代谢转变可能是一种应对抗生素的生存策略,通过乙醇生产氧化NADH来避免呼吸作用产生ROS。编码一种隐蔽原噬菌体的单菌素基因座被复方新诺明诱导,并被氨苄青霉素和庆大霉素抑制,这与观察到的抗生素依赖性生物膜形成相关。单菌素突变体(ΔlmaDCBA)在暴露于浓度不断增加的复方新诺明时,与野生型类似,生物膜形成增加,但对复方新诺明和氨苄青霉素的杀伤更具耐受性。因此,亚致死浓度的抗生素会引起代谢和生理变化,表明该生物体正在为抵御致死浓度的抗生素做准备。